Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

37 та иш

Иш: Design of Tripeptides as a Competitive Inhibitor for HMG-CoA Reductase

  1. Syrian Hamster 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Expressed in Escherichia coli: Production of Homogeneous Protein

    Kenneth Frimpong, Bryant G. Darnay, V.W. Rodwell

    Мақола19934 иқтибос
    ABI

  2. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes

    F. William Studier, Barbara A. Moffatt

    Мақола19864 иқтибос
    ABI

  3. Biomedical applications of dipeptides and tripeptides

    Sara Santos, Inês M. Torcato, Miguel A. R. B. Castanho

    Шарҳ мақола20124 иқтибос
    ABI

  4. Structure-Based Drug Design: Docking and Scoring

    Romano T. Kroemer

    Шарҳ мақола20074 иқтибос
    ABI

  5. The Natural Products as Hydroxymethylglutaryl-Coa Reductase Inhibitors

    Hayrettin Ozan Gülcan, Serkan Yiğitkan, İlkay Erdoğan Orhan

    Мақола20184 иқтибос
    ABI

  6. Inhibitor design for <scp>3‐hydroxy‐3‐methyl‐glutaryl‐CoA</scp> reductase enzyme; molecular docking and determination of molecular and electronic properties of ligands by density functional theory method

    Selami Ercan, Ercan Çınar, Cihat Özaydın +2

    Мақола20204 иқтибос
    ABI

  7. Low High-Density Lipoprotein Cholesterol and Increased Cardiovascular Disease Risk: An Analysis of Statin Clinical Trials

    Prakash Deedwania, Vibhuti Singh, Michael H. Davidson

    Мақола20093 иқтибос
    ABI

  8. Hypercholesterolemia As a Risk Factor for Cardiovascular Disease: Current Controversial Therapeutic Management

    Arturo Zárate, Leticia Manuel‐Apolinar, Renata Saucedo +2

    Шарҳ мақола20163 иқтибос
    ABI

  9. Molecular aspects of hypercholesterolemia treatment: current perspectives and hopes

    Najmeh Ahangari, Majid Ghayour‐Mobarhan, Amirhossein Sahebkar +1

    Шарҳ мақола20183 иқтибос
    ABI

  10. Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1.5 Million Patients

    L. Masana, Alberto Zamora, Núria Plana +9

    Мақола20193 иқтибос
    ABI

  11. Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total Mortality

    Patricia R. Hebert, J. Michael Gaziano, Ki Sau Chan +1

    Мақола19982 иқтибос
    ABI

  12. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI